The role of MEKK1-dependent gene expression in tumor progression
MEKK1依赖性基因表达在肿瘤进展中的作用
基本信息
- 批准号:7666286
- 负责人:
- 金额:$ 15.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-16 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAnimalsAreaBasement membraneBioinformaticsBiological AssayBiologyBiomedical ResearchBreast AdenocarcinomaBreast CarcinomaCancer CenterCandidate Disease GeneCell LineCell ProliferationCell physiologyCellsCellular biologyCessation of lifeCommitConditioned Culture MediaCore FacilityDevelopmentEnvironmentFacultyFibroblastsGelatinase BGene ExpressionGene TargetingGenesGeneticGenetic ScreeningGenetic TranscriptionGoalsGrowthHome environmentHumanIL8 geneImageIn VitroLaboratoriesLifeLightMAP Kinase GeneMAP3K1 geneMAPK14 geneMAPK8 geneMalignant Epithelial CellMalignant NeoplasmsMammary NeoplasmsMammary glandMatrix MetalloproteinasesMediatingMentorsMethodsMitogen-Activated Protein Kinase InhibitorModelingMusMutationNeoplasm MetastasisOncogenesOrganOrgan SpecificityPathway interactionsPeptide HydrolasesPhenotypePhosphotransferasesPlatelet-Derived Growth FactorPolyomavirusPopulationPrimary NeoplasmRegulationRelative (related person)ResearchResearch PersonnelResearch Project GrantsReverse Transcriptase Polymerase Chain ReactionRoleSeriesSignal TransductionSmall Interfering RNASolid NeoplasmStagingStromal Cell-Derived Factor 1Stromal NeoplasmStromelysin 1SystemTechnologyTestingTherapeutic InterventionTimeTissue Inhibitor of Metalloproteinase-1Tissue Inhibitor of Metalloproteinase-3TissuesTrainingTranscription Factor AP-1Transgenic MiceTumor Cell InvasionTumor Cell LineValidationVascular Endothelial Growth FactorsViral Tumor AntigensXenograft procedureangiogenesisbasecareercell motilitycell stromacell typecellular imagingcollagenase 3computing resourcesexperiencefos-related antigen-2gene functionin vitro Assayin vivoknock-downluminescencemigrationmouse modelneoplastic cellresponsesialosyl-T antigensmall hairpin RNAtumortumor growthtumor progressiontumor xenograft
项目摘要
DESCRIPTION (provided by applicant): My career plans are in academic biomedical research. I have received broad training in the characterization of kinase signaling and function. However, a major focus of my independent research will be the identification of genetic changes mediated by signaling networks; this requires new areas of expertise in array-based genetic screens and animal models to identify potential targets for therapeutic intervention. Gary Johnson is an excellent choice as my mentor in light of his experience in training researchers and his proven ability to address important questions of signaling function in cell biology. My co-mentors Drs. Van Dyke and Perou are also committed to my training and have considerable experience in approaches and methods required in my research. The UNC Lineberger Cancer Center is home to CORE facilities that will provide support throughout the research project. Thus UNC provides an outstanding scientific environment that also includes interaction with senior faculty and participation in seminar series. The goal of this project is to define the role of MEKK1 signaling in the regulation of tumor progression. MEKK1 regulates gene expression by controlling AP-1 transcription factor activity, expression and stability. In a transgenic mouse model that develops metastatic mammary adenocarcinoma, MEKK1-deficient transgenic mice show delayed formation of metastases compared to control littermates. The hypothesis is that MEKK1 regulates tumor progression through multiple mechanisms. The proposed studies will determine the impact of MEKK1 on gene expression required for tumor progression. MEKK1-dependent genes will be identified by using gene array analysis to compare MEKK1-deficient cells to those that express MEKK1. Expression of these genes will be blocked in invasive breast carcinoma cells to verify that these genes regulate tumor functions required for metastasis. Live tumor imaging will be used to validate the function of these genes on the course of tumor cell metastasis in vivo. In addition, I will examine the role of previously identified MEKK1-dependent genes in the biology of breast tumor cells and non-tumor stroma. Relevance: The majority of cancer deaths are due to the formation of secondary tumors called metastasis. Greater understanding of metastasis-related mechanisms and genetics is necessary to develop new anti-metastasis therapies. MEKK1 is a gene that regulates tumor metastasis, and these studies will define how this occurs.
描述(由申请人提供):我的职业计划是学术生物医学研究。我接受了激酶信号传导和功能表征方面的广泛培训。然而,我独立研究的一个主要重点将是识别信号网络介导的遗传变化;这需要基于阵列的遗传筛查和动物模型方面的新专业知识领域,以确定治疗干预的潜在目标。加里·约翰逊(Gary Johnson)是我的导师的绝佳选择,因为他在培训研究人员方面拥有丰富的经验,而且他在解决细胞生物学信号功能重要问题方面的能力已得到证实。我的共同导师博士。范戴克和佩鲁也致力于我的培训,并且在我的研究所需的方法和方法方面拥有丰富的经验。北卡罗来纳大学莱恩伯格癌症中心拥有核心设施,将为整个研究项目提供支持。因此,北卡罗来纳大学提供了一个出色的科学环境,其中还包括与高级教师的互动和参加系列研讨会。该项目的目标是明确 MEKK1 信号传导在肿瘤进展调节中的作用。 MEKK1 通过控制 AP-1 转录因子的活性、表达和稳定性来调节基因表达。在发生转移性乳腺癌的转基因小鼠模型中,与对照同窝小鼠相比,MEKK1 缺陷的转基因小鼠显示出转移形成延迟。假设 MEKK1 通过多种机制调节肿瘤进展。拟议的研究将确定 MEKK1 对肿瘤进展所需基因表达的影响。通过使用基因阵列分析将 MEKK1 缺陷细胞与表达 MEKK1 的细胞进行比较来鉴定 MEKK1 依赖性基因。这些基因的表达将在侵袭性乳腺癌细胞中被阻断,以验证这些基因调节转移所需的肿瘤功能。活体肿瘤成像将用于验证这些基因在体内肿瘤细胞转移过程中的功能。此外,我将研究先前确定的 MEKK1 依赖性基因在乳腺肿瘤细胞和非肿瘤基质生物学中的作用。相关性:大多数癌症死亡是由于称为转移的继发性肿瘤的形成。开发新的抗转移疗法需要更好地了解转移相关机制和遗传学。 MEKK1 是一种调节肿瘤转移的基因,这些研究将确定这种情况是如何发生的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce D Cuevas其他文献
Bruce D Cuevas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce D Cuevas', 18)}}的其他基金
The role of MEKK1-dependent gene expression in tumor progression
MEKK1依赖性基因表达在肿瘤进展中的作用
- 批准号:
7618928 - 财政年份:2007
- 资助金额:
$ 15.04万 - 项目类别:
The role of MEKK1-dependent gene expression in tumor progression
MEKK1依赖性基因表达在肿瘤进展中的作用
- 批准号:
7895607 - 财政年份:2007
- 资助金额:
$ 15.04万 - 项目类别:
The role of MEKK1-dependent gene expression in tumor progression
MEKK1依赖性基因表达在肿瘤进展中的作用
- 批准号:
7485818 - 财政年份:2007
- 资助金额:
$ 15.04万 - 项目类别:
The role of MEKK1-dependent gene expression in tumor progression
MEKK1依赖性基因表达在肿瘤进展中的作用
- 批准号:
7209658 - 财政年份:2007
- 资助金额:
$ 15.04万 - 项目类别:
The role of MEKK1-dependent gene expression in tumor progression
MEKK1依赖性基因表达在肿瘤进展中的作用
- 批准号:
8115171 - 财政年份:2007
- 资助金额:
$ 15.04万 - 项目类别:
MEKK2/3-MEK5 Interaction/Activation/ERK5 Pathway(RMI)
MEKK2/3-MEK5 相互作用/激活/ERK5 通路(RMI)
- 批准号:
7021866 - 财政年份:2005
- 资助金额:
$ 15.04万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
利用肝癌动物模型开展化学可控的在体基因编辑体系的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Effects of tACS on alcohol-induced cognitive and neurochemical deficits
tACS 对酒精引起的认知和神经化学缺陷的影响
- 批准号:
10825849 - 财政年份:2024
- 资助金额:
$ 15.04万 - 项目类别:
Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10556857 - 财政年份:2023
- 资助金额:
$ 15.04万 - 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 15.04万 - 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 15.04万 - 项目类别: